GlassScriptPhysician profile
Michael G Russo
NPI 1194887125
$10,983.96
in general payments reported to CMS, 2019-2025
57 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $1,645 · 2021: $1,971 · 2022: $1,527 · 2023: $1,517 · 2024: $1,340 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,069 · Education: $1.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,069.27 |
| Education | $1.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,512.83 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $1,378.22 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $817.67 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $772.85 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $715.82 | 2019-2021 | |
| Allergan, INC. | $510.65 | 2019-2021 | |
| Novo Nordisk INC | $441.22 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $343.89 | 2019-2024 | Xarelto |
| Vanda Pharmaceuticals INC. | $310.25 | 2019-2025 | Fanapt, Hetlioz, Ponvory |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.22 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $248.71 | 2019-2023 | Trulicity |
| Otsuka America Pharmaceutical, INC. | $243.47 | 2019-2025 | Rexulti, Abilify Maintena |
| Avanir Pharmaceuticals, INC. | $239.65 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.69 | 2019-2024 | Trulance, Xifaxan |
| Novartis Pharmaceuticals Corporation | $217.01 | 2019-2022 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $205.96 | 2021-2025 | Caplyta |
| Ucb, INC. | $201.36 | 2019-2024 | Nayzilam, Briviact |
| E.R. Squibb & Sons, L.L.C. | $193.57 | 2019-2025 | Eliquis |
| Merck Sharp & Dohme LLC | $192.11 | 2020-2023 | Verquvo, Belsomra, Steglatro |
| Corcept Therapeutics | $182.87 | 2023-2025 | Korlym |
| Acadia Pharmaceuticals INC | $180.01 | 2020-2022 | |
| Pfizer INC. | $154.71 | 2019-2025 | |
| Smith+Nephew, INC. | $104.78 | 2019-2021 | |
| Neurelis, INC. | $94.37 | 2021-2023 | Valtoco |
| Indivior INC. | $79.53 | 2019-2025 | Sublocade |
| Amgen INC. | $78.94 | 2019-2024 | Repatha, Otezla |
| Kowa Pharmaceuticals America, INC. | $76.68 | 2021-2025 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $75.93 | 2020-2025 | Austedo Xr |
| Xeris Pharmaceuticals, INC. | $72.79 | 2023-2024 | Keveyis |
| Almatica Pharma LLC | $64.42 | 2021-2022 | |
| Lundbeck LLC | $61.16 | 2023-2025 | Rexulti |
| Abbott Laboratories | $58.32 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $54.80 | 2021 | |
| Biogen, INC. | $45.83 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.74 | 2019-2021 | |
| Eisai INC. | $43.01 | 2020 | |
| Nestle Healthcare Nutrition INC. | $40.35 | 2020-2022 | |
| Adamas Pharmaceuticals, INC. | $38.87 | 2020-2021 | |
| Mylan Specialty L.P. | $35.29 | 2020-2021 | |
| Ardelyx, INC. | $25.99 | 2024 | Ibsrela |
| Aimmune Therapeutics, INC. | $25.03 | 2025 | Zenpep |
| Dexcom, INC. | $23.87 | 2024 | Dexcom G6 Transmitter |
| Jazz Pharmaceuticals INC. | $23.28 | 2021 | |
| Evoke Pharma, INC. | $22.79 | 2020 | |
| Alkermes, INC. | $22.71 | 2022 | |
| Daiichi Sankyo INC. | $22.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $21.07 | 2022 | |
| Astellas Pharma US INC | $20.25 | 2025 | Veozah |
| Celgene Corporation | $18.84 | 2023 | Zeposia |
| Acorda Therapeutics, INC | $17.95 | 2019 | |
| Esperion Therapeutics, INC. | $16.67 | 2020 | |
| Exact Sciences Corporation | $16.16 | 2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $15.35 | 2023 | Inspire |
| Emd Serono, INC. | $15.29 | 2021 | |
| Kaleo, INC. | $14.68 | 2019 | |
| Becton, Dickinson and Company | $13.36 | 2022 | |
| Gilead Sciences, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.